Table 3.
Magnetic Resonance Imaging Characteristics at ON Onset in Patients with LO-NMOSD-ON and Patients with EO-NMOSD-ON: Segmental Enhancement of AVPs
Segmental Enhancement of AVPs | LO-NMOSD-ON (n = 10 AVPs) |
EO-NMOSD-ON (n = 24 AVPs) |
p-value |
---|---|---|---|
▫ Segmental enhancement of AVPs, n of AVPs with each enhanced segment/n of available AVPs (%) | |||
|
8/10 (80.0%) | 17/24 (70.8%) | 0.69 |
|
6/10 (60.0%) | 19/24 (79.1%) | 0.39 |
|
2/10 (20.0%) | 13/24 (54.1%) | 0.12 |
|
0/10 (0.0%) | 4/24 (16.6%) | 0.29 |
|
0/10 (0.0%) | 1/24 (4.1%) | 1.00 0.43 |
|
6/10 (60.0%) | 18/24 (75.0%) | |
▫ Total enhanced segments, mean ± standard deviation, segments | 1.60 ± 0.51 | 2.20 ± 1.02 | 0.08 |
Abbreviations: LO-NMOSD-ON, late-onset neuromyelitis optica spectrum disorder-related optic neuritis; EO-NMOSD-ON, early-onset neuromyelitis optica spectrum disorder-related optic neuritis; ON, optic neuritis; AVP, anterior visual pathway; n, number.